Franklin Biotechnology Discovery Fund I(acc)USDRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 17,6 | -10,4 | -6,0 | 14,6 | 7,9 | |
+/-Kat | -1,2 | -7,3 | 6,8 | 13,2 | 10,2 | |
+/-Indeks | -7,8 | -17,2 | -2,9 | 4,4 | -0,2 | |
Kategori: Sektor - Bioteknologi, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Biotechnolo... |
Oversigt | ||
Seneste NAV 03-05-2024 | USD 65,70 | |
Kursændring 1 dag | 0,40% | |
Morningstar Kategori™ | Sektor - Bioteknologi, Aktier | |
ISIN | LU0195948822 | |
Markedsværdi i alt (mio.) 31-03-2024 | USD 1785,11 | |
Seneste TNA(mio.) 03-05-2024 | USD 118,71 | |
Emissionstillæg | - | |
Løbende omkostning 04-03-2024 | 0,96% | |
Investeringsstrategi | Aktiv |
Morningstar Research |
Analyst Report | 13-10-2023 Katie Rushkewicz Reichart, Director Morningstar, Inc |
Franklin Biotechnology Discovery is overseen by experienced managers, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.This strategy’s compact team is composed of three managers who have... | |
Klik her for analytikerens rapport |
Morningstar Søjler | |
---|---|
Team | 23 |
Forening | 23 |
Proces | 23 |
Resultater | |
Omkostninger |
Investeringsmålsætning: Franklin Biotechnology Discovery Fund I(acc)USD |
The Fund’s investment objective is capital appreciation. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Evan McCulloch 01-11-2000 | ||
Wendy Lam 01-09-2018 | ||
Klik her for at se flere | ||
Startdato 31-08-2004 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
NASDAQ Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Franklin Biotechnology Discovery Fund I(acc)USD | 31-03-2024 |
|
|
Top 5 placeringer | Sektor | % |
Amgen Inc | Healthcare | 6,85 |
Regeneron Pharmaceuticals Inc | Healthcare | 6,43 |
Vertex Pharmaceuticals Inc | Healthcare | 5,34 |
Ascendis Pharma A/S ADR | Healthcare | 4,22 |
Gilead Sciences Inc | Healthcare | 3,07 |
Øget Mindsket Ny siden sidste portefølje | ||
Franklin Biotechnology Discovery Fund I(acc)USD |